Technology Review - Published By MIT
Advertisement
TO READ THIS STORY - you must have a paid subscription to Technology Review OR you can purchase special archive reading credits here. Choose from these great offers below.
I'm a paid subscriber please
log me in
I want to purchase this article for
only $1.99
(requires login)
I want to purchase five articles for
only $7.99
(requires login)
I want to buy
1 Year TOTAL Access for
only $24.95
(requires login)

Please note: Click here if you are currently a Technology Review print or digital subscriber and do not have access to this article.

March 2003

The Liver Chip

The human liver cells in Linda Griffith's miniature device behave just as they would in the body, permitting more accurate drug and toxin testing.

By Rebecca Zacks

Several years ago, MIT tissue engineer Linda Griffith set out to build an artificial liver that could eliminate the need for donated organs for transplant. Then she had a realization: the most common reason for needing a liver transplant is a hepatitis C infection, and "if it were me, I'd rather not have a liver transplant. I'd rather the doctor said, Here, take these drugs; you will be cured of hepatitis C; you'll go on and lead a happy life; and you'll stay out of the operating room.'" But researchers have a hard time developing drugs for hepatitis C and other ailments because animal experiments don't always reveal what happens in humans, and human cells in a petri dish don't always function the way they would in the body. Indeed, hepatitis viruses don't even infect human liver cells in a petri dish. So Griffith and her team are putting their tissue-engineering expertise to work building what's essentially a miniature human liver on a silicon chip. It won't serve as a replacement part but rather as an amazingly realistic model of the natural organ. "What we're trying to do is replicate the structure, as well as the mechanical forces, so that we can hopefully replicate the function," she explains. Mass produced, such a chip could be a boon not only to companies developing drugs for hepatitis and other diseases, but also for scientists investigating liver cancer and gene therapy, and even chemical firms testing the toxicity of new materials. Griffith and graduate student Albert Hwa showed Technology Review senior editor Rebecca Zacks how to build a little liver.

Select from the choices above
to read the entire article.


Log In

Forgot your password?     Register »
Advertisement

Videos

Microsoft's Many Multitouch Mice
Featured Content
Sponsored by:
White Papers

Twelve ways to reduce costs with SQL Server 2008
Find out how to reduce costs and get more efficient

Download

Total Economic Impact of SQL Server 2008 Upgrade
Forrester reports on increasing productivity and management capabilities

Download 

Achieving Cost and Resource Savings with UC
How Office Communications Server R2 and Exchange Server can make your business smarter and more efficient

Download 

The Compelling Case for Conferencing
Read how you can improve workload support and find IT efficiencies

Download

How Windows Server 2008 R2 Helps Optimize IT and Save you Money
Read how you can improve workload support and find IT efficiencies

Download

Windows Server 2008 R2 Hyper-V Live Migration
See how Windows Server 2008 R2 and Hyper-V enable virtualization and Live Migration

Download
Advertisement
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address

TECHNOLOGY RESOURCES
Advertisement
MIT Massachusetts Institute of Technology © 2009 Technology Review. All Rights Reserved.